{
    "root": "65cb518c-dec1-471f-aca8-d0431c7091c9",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "SEVOFLURANE",
    "value": "20250430",
    "ingredients": [
        {
            "name": "SEVOFLURANE",
            "code": "38LVP0K73A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9130"
        }
    ],
    "indications": {
        "text": "sevoflurane indicated induction maintenance general anesthesia adult pediatric patients inpatient outpatient surgery . sevoflurane administered persons trained general anesthesia . facilities maintenance patent airway , artificial ventilation , oxygen enrichment , circulatory resuscitation must immediately available . since level anesthesia may altered rapidly , vaporizers producing predictable concentrations sevoflurane used .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "concentration sevoflurane delivered vaporizer known . may accomplished using vaporizer calibrated specifically sevoflurane . general anesthesia must individualized based patient \u2019 response .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "sevoflurane , usp , volatile liquid inhalation , available : ndc 10019-653-64 - aluminum bottle plastic screw-on cap containing 250 ml sevoflurane , usp . ndc 10019-657-06 - aluminum bottle integrated crimped-on valve closure containing 250 ml sevoflurane , usp .",
    "adverseReactions": "\u2022known suspected genetic susceptibility malignant hyperthermia ( - malignant hyperthermia , pharmacology \u2013 pharmacogenomics ) . \u2022known suspected sensitivity sevoflurane halogenated inhalational anesthetics .",
    "indications_original": "Sevoflurane is indicated for induction and maintenance of general anesthesia in adult and pediatric patients for inpatient and outpatient surgery.\n                  Sevoflurane should be administered only by persons trained in the administration of general anesthesia. Facilities for maintenance of a patent airway, artificial ventilation, oxygen enrichment, and circulatory resuscitation must be immediately available. Since level of anesthesia may be altered rapidly, only vaporizers producing predictable concentrations of sevoflurane should be used.",
    "contraindications_original": "The concentration of sevoflurane being delivered from a vaporizer should be known. This may be accomplished by using a vaporizer calibrated specifically for sevoflurane. The administration of general anesthesia must be individualized based on the patient\u2019s response.",
    "warningsAndPrecautions_original": "Sevoflurane, USP, Volatile Liquid for Inhalation, is available as:\n                  \n                     \n                        \u00a0NDC 10019-653-64 - Aluminum bottle with plastic screw-on cap containing 250 mL sevoflurane, USP.\n                     \n                        \u00a0NDC 10019-657-06 - Aluminum bottle with an integrated crimped-on valve closure containing 250 mL sevoflurane, USP.",
    "adverseReactions_original": "\u2022Known or suspected genetic susceptibility to malignant hyperthermia (see WARNINGS - Malignant Hyperthermia, CLINICAL PHARMACOLOGY \u2013 Pharmacogenomics).\n                     \n                        \u2022Known or suspected sensitivity to sevoflurane or to other halogenated inhalational anesthetics.",
    "drug": [
        {
            "name": "SEVOFLURANE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9130"
        }
    ]
}